Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 12:22 pm Sale | 2022-02-14 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,049,133 4.000% | -726,503 (-26.17%) | Filing History |
| 2022-02-10 08:16 am Purchase | 2021-12-31 | 13G | Haemonetics Corporation HAE | The Vanguard Group | 4,880,936 9.550% | 28,654 (+0.59%) | Filing History |
| 2022-02-10 07:48 am Purchase | 2022-01-31 | 13G | Haemonetics Corporation HAE | Wellington Management Group LLP | 5,537,538 10.830% | 447,237 (+8.79%) | Filing History |
| 2022-02-04 09:27 am Purchase | 2021-12-31 | 13G | Haemonetics Corporation HAE | Wellington Management Group LLP | 5,090,301 9.960% | 2,837,909 (+126.00%) | Filing History |
| 2022-01-26 8:18 pm Unchanged | 2021-12-31 | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 6,692,346 13.100% | 0 (Unchanged) | Filing History |
| 2022-01-25 11:15 am Purchase | 2021-12-31 | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 6,692,346 13.100% | 713,043 (+11.93%) | Filing History |
| 2021-07-09 6:05 pm Purchase | 2021-06-30 | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 5,979,303 11.700% | 1,278,712 (+27.20%) | Filing History |
| 2021-06-10 11:46 am Sale | 2021-06-10 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 2,775,636 5.400% | -2,862,099 (-50.77%) | Filing History |
| 2021-02-16 3:11 pm Purchase | 2021-02-16 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,637,735 11.100% | 437,670 (+8.42%) | Filing History |
| 2021-02-11 7:05 pm Purchase | 2020-12-31 | 13G | Haemonetics Corporation HAE | Neuberger Berman Group LLC | 2,833,049 5.570% | 221,133 (+8.47%) | Filing History |
| 2021-02-10 10:57 am Sale | 2020-12-31 | 13G | Haemonetics Corporation HAE | The Vanguard Group | 4,852,282 9.560% | -378,913 (-7.24%) | Filing History |
| 2021-01-29 09:56 am Sale | 2020-12-31 | 13G | Haemonetics Corporation HAE | BlackRock Inc. BLK | 4,700,591 9.300% | -1,210,269 (-20.48%) | Filing History |
| 2020-11-10 12:33 pm Purchase | 2020-11-10 | 13G | Haemonetics Corporation HAE | Capital Research Global Investors | 5,200,065 10.200% | 2,505,265 (+92.97%) | Filing History |